Login / Signup

Increased reporting of cerebrovascular accidents with use of risankizumab observed in the FDA Adverse Events Reporting System (FAERS).

Alexander EgebergJacob P Thyssen
Published in: The British journal of dermatology (2023)
Keyphrases
  • adverse drug
  • emergency department
  • drug induced
  • drug administration